FibroScan’s evolution: a critical 20-year review
Journal of Ultrasound · 2024
DOI: 10.1007/s40477-024-00971-z ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Ultrasound, 2024. Verfasst von Nisar Ahmed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Aditya Pharmacy Collage, Surampalem, Andhra Pradesh, India. nisarmehdinager786@gmail.com. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Liver Cirrhosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
FibroScan, initially designed for assessing cheese maturity, has evolved into a crucial medical tool for liver fibrosis diagnosis. This systematic review explores its development history, functionality, and pros and cons compared to traditional liver biopsy. Precision in various clinical settings is scrutinised, emphasising FibroScan's accuracy in conditions like NAFLD and viral-induced liver disease. The article also delves into its potential in paediatrics, its relevance in monitoring COVID-19-related liver complications, and its role in predicting hepatocellular carcinoma risk, Technical aspects, including transducers, imaging integration, and portability, are examined. Various methods for evaluating liver fibrosis are discussed, highlighting FibroScan's suitability for advanced stages, contrasting with the gold standard of liver biopsy for early stages. The impact of FibroScan on long-term liver conditions is emphasised, focusing on early detection, progression monitoring, reduced invasive biopsies, and hepatocellular carcinoma risk prediction. This systematic review underscores FibroScan's transformative potential in liver disease treatment and predicts ongoing research to enhance early detection, disease monitoring, and explore new clinical applications. Anticipated advances include FibroScan-guided liver biopsy, artificial intelligence data analysis, and point-of-care device development, promising a further revolution in liver disease management. The article concludes with optimistic prospects for FibroScan's future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aditya Pharmacy Collage, Surampalem, Andhra Pradesh, India. nisarmehdinager786@gmail.com.
- Jawaharlal Nehru Technological University, Kakinada, India. nisarmehdinager786@gmail.com.
- Aditya Pharmacy Collage, Surampalem, Andhra Pradesh, India.
- Jawaharlal Nehru Technological University, Kakinada, India.
- AIIMS, New Delhi, India.
Zitieren
APA
Ahmed, N., Kumari, A., & Murty, R. S. (2024). FibroScan’s evolution: a critical 20-year review. Journal of Ultrasound. https://doi.org/10.1007/s40477-024-00971-z
Vancouver
Ahmed N, Kumari A, Murty RS. FibroScan’s evolution: a critical 20-year review. Journal of Ultrasound. 2024. doi:10.1007/s40477-024-00971-z
BibTeX
@article{Ahmed2024,
author = {Ahmed, Nisar and Kumari, Ayushi and Murty, R Srinivasa},
title = {FibroScan’s evolution: a critical 20-year review},
journal = {Journal of Ultrasound},
year = {2024},
doi = {10.1007/s40477-024-00971-z}
}
EUVIMED